201 related articles for article (PubMed ID: 37327563)
1. Pharmacogenetic testing in psychiatry: Perspective on clinical utility.
Adiukwu F; Adesokun O; Essien E; Yalcin N; Ransing R; Nagendrappa S; Jatchavala C; Olakunke AB; Nawaz FA; Khan N
Asian J Psychiatr; 2023 Aug; 86():103674. PubMed ID: 37327563
[TBL] [Abstract][Full Text] [Related]
2. Barriers to clinical adoption of pharmacogenomic testing in psychiatry: a critical analysis.
Virelli CR; Mohiuddin AG; Kennedy JL
Transl Psychiatry; 2021 Oct; 11(1):509. PubMed ID: 34615849
[TBL] [Abstract][Full Text] [Related]
3. Providers' perspectives on the clinical utility of pharmacogenomic testing in pediatric patients.
Liko I; Lee YM; Stutzman DL; Blackmer AB; Deininger KM; Reynolds AM; Aquilante CL
Pharmacogenomics; 2021 Apr; 22(5):263-274. PubMed ID: 33657875
[No Abstract] [Full Text] [Related]
4. Unraveling heterogeneity of the clinical pharmacogenomic guidelines in oncology practice among major regulatory bodies.
Nagy M; Attya M; Patrinos GP
Pharmacogenomics; 2020 Nov; 21(17):1247-1264. PubMed ID: 33124490
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenetics in psychiatric care, a call for uptake of available applications.
Lunenburg CATC; Gasse C
Psychiatry Res; 2020 Oct; 292():113336. PubMed ID: 32739644
[TBL] [Abstract][Full Text] [Related]
6. PGx in psychiatry: Patients' knowledge, interest, and uncertainty management preferences in the context of pharmacogenomic testing.
Kastrinos A; Campbell-Salome G; Shelton S; Peterson EB; Bylund CL
Patient Educ Couns; 2021 Apr; 104(4):732-738. PubMed ID: 33414028
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetic Information in Clinical Guidelines: The European Perspective.
Swen JJ; Nijenhuis M; van Rhenen M; de Boer-Veger NJ; Buunk AM; Houwink EJF; Mulder H; Rongen GA; van Schaik RHN; van der Weide J; Wilffert B; Deneer VHM; Guchelaar HJ;
Clin Pharmacol Ther; 2018 May; 103(5):795-801. PubMed ID: 29460273
[TBL] [Abstract][Full Text] [Related]
8. Comparison of FDA Table of Pharmacogenetic Associations and Clinical Pharmacogenetics Implementation Consortium guidelines.
Pritchard D; Patel JN; Stephens LE; McLeod HL
Am J Health Syst Pharm; 2022 Jun; 79(12):993-1005. PubMed ID: 35230418
[TBL] [Abstract][Full Text] [Related]
9. Use of a consultation service following pharmacogenetic testing in psychiatry.
Krause DS; Dowd D
Pharmacogenomics; 2022 Apr; 23(5):327-333. PubMed ID: 35296147
[TBL] [Abstract][Full Text] [Related]
10. Towards the integration of pharmacogenetics in psychiatry: a minimum, evidence-based genetic testing panel.
Bousman C; Maruf AA; Müller DJ
Curr Opin Psychiatry; 2019 Jan; 32(1):7-15. PubMed ID: 30299306
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications.
Malik S; Verma P; Ruaño G; Al Siaghy A; Dilawar A; Bishop JR; Strawn JR; Namerow LB
J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):4-20. PubMed ID: 38377525
[TBL] [Abstract][Full Text] [Related]
12. Deliberations about clinical pharmacogenetic testing in pediatric oncology.
Issa AM; Aboushawareb SA; Eisenstat DD; Guilcher GM; Liu G; Rassekh SR; Strahlendorf C; Tallen G; Tanoshima R; Carleton B
Per Med; 2021 Jul; 18(4):399-405. PubMed ID: 33973801
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in psychiatry: translating research into clinical practice.
Malhotra AK; Zhang JP; Lencz T
Mol Psychiatry; 2012 Jul; 17(8):760-9. PubMed ID: 22083729
[TBL] [Abstract][Full Text] [Related]
14. A Narrative Review on Pharmacogenomics in Psychiatry: Scientific Definitions, Principles, and Practical Resources.
Palumbo S; Mariotti V; Pellegrini S
J Clin Psychopharmacol; 2024 Jan-Feb 01; 44(1):49-56. PubMed ID: 38100778
[TBL] [Abstract][Full Text] [Related]
15. Perspectives on the Clinical Use of Pharmacogenetic Testing in Late-Life Mental Healthcare: A Survey of the American Association of Geriatric Psychiatry Membership.
Bousman CA; Oomen A; Jessel CD; Tampi RR; Forester BP; Eyre HA; Lavretsky H; Müller DJ
Am J Geriatr Psychiatry; 2022 May; 30(5):560-571. PubMed ID: 34740522
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics - a minor rather than major force in clinical medicine.
Polasek TM
Expert Rev Clin Pharmacol; 2024 Mar; 17(3):203-212. PubMed ID: 38307498
[TBL] [Abstract][Full Text] [Related]
17. Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosing.
Mostafa S; Polasek TM; Bousman CA; Müeller DJ; Sheffield LJ; Rembach J; Kirkpatrick CM
Pharmacogenomics; 2022 Oct; 23(15):857-867. PubMed ID: 36169629
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenomic testing in paediatrics: Clinical implementation strategies.
Barker CIS; Groeneweg G; Maitland-van der Zee AH; Rieder MJ; Hawcutt DB; Hubbard TJ; Swen JJ; Carleton BC
Br J Clin Pharmacol; 2022 Oct; 88(10):4297-4310. PubMed ID: 34907575
[TBL] [Abstract][Full Text] [Related]
19. Interventional cardiologists' attitudes towards pharmacogenetic testing and impact on antiplatelet prescribing decisions.
Hoffecker G; Kanter GP; Xu Y; Matthai W; Kolansky DM; Giri J; Tuteja S
Per Med; 2022 Jan; 19(1):41-49. PubMed ID: 34881641
[TBL] [Abstract][Full Text] [Related]
20. Acceptability, Feasibility, and Utility of Integrating Pharmacogenetic Testing into a Child Psychiatry Clinic.
Claudio-Campos K; Padrón A; Jerkins G; Nainaparampil J; Nelson R; Martin A; Wiisanen K; Smith DM; Strekalova Y; Marsiske M; Cicali EJ; Cavallari LH; Mathews CA
Clin Transl Sci; 2021 Mar; 14(2):589-598. PubMed ID: 33166056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
